Loading data
Company
JOHNSON & JOHNSON
JNJNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 94.19 bn USD | 88.82 bn USD | 85.16 bn USD | 79.99 bn USD | 78.74 bn USD |
| Cost of revenue | 30.26 bn USD | 27.47 bn USD | 26.55 bn USD | 24.6 bn USD | 23.4 bn USD |
| Gross profit | 63.94 bn USD | 61.35 bn USD | 58.61 bn USD | 55.39 bn USD | 55.34 bn USD |
| Research and development expense | 109 m USD | 1.84 bn USD | 483 m USD | 0 USD | 0 USD |
| Selling, general and administrative expense | 23.68 bn USD | 22.87 bn USD | 21.51 bn USD | 20.25 bn USD | 20.12 bn USD |
| Interest expense | — | — | 772 m USD | 276 m USD | 183 m USD |
| Profit before tax | 32.58 bn USD | 16.69 bn USD | 15.06 bn USD | 19.36 bn USD | 19.18 bn USD |
| Income tax expense | 5.78 bn USD | 2.62 bn USD | 1.74 bn USD | 2.99 bn USD | 1.38 bn USD |
| Net income (reported basis) | 26.8 bn USD | 14.07 bn USD | 35.15 bn USD | 17.94 bn USD | 20.88 bn USD |
| Basic earnings per share | 11.13 USD/share | 5.84 USD/share | 13.88 USD/share | 6.83 USD/share | 7.93 USD/share |
| Diluted earnings per share | 11.03 USD/share | 5.79 USD/share | 13.72 USD/share | 6.73 USD/share | 7.81 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.